Dal Pan G, Spooner A, Morrato E, Smith M, Jones J, Wise L, Gilsenan A. Introduction to the evaluation of therapeutic risk management programs. Presented at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE); August 24, 2016. Dublin, Ireland. Previously presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management.
Hollis K, Gilsenan A. Design and implementation of surveys to assess patient and healthcare provider understanding of risks and safe use conditions. In: Andrews EB, Moore N, editors. Mann's pharmacovigilance. 3rd ed. Chichester, West Sussex, UK: UK. Wiley-Blackwell; 2014.doi: 10.1002/9781118820186.ch49.
The power of knowledge. The value of understanding.
Steeped in a tradition of rigor and process, we maintain a legacy of setting the scientific standards within our industry. We employ the right approaches and proven research practices to analyze evidence and draw meaningful insights. Our uncompromisingly ethical and objective researchers ensure that results will hold up to scrutiny and reveal the benefits, risks, value and potential of your products. Learn more.